CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 88 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05724706
NCT05724706N/ACompleted

An Evaluation of Salivary Oxidant and Antioxidant Levels in Peri-implant Health and Disease

Biruni University·observational·Posted Feb 13, 2023·Updated Feb 13, 2023

In Brief

An observational study for Peri-Implantitis and 4 related conditions. Completed, enrolled 88 participants.

Detailed Summary

Objectives: Inflammatory lesions develop in the tissues surrounding implants are referred to as peri-implant diseases. Oxidants, play a role in inflammatory lesions. The study aimed to determine oxidant and antioxidant levels in the saliva of patients with various levels of peri-implant diseases and the relationship between oxidative stress and peri-implant diseases. Material and methods: Sixty-seven patients with at least one dental implant applied in our clinic were included in the study. The patients were divided into 3 groups; with peri-implantitis (PI), with marginal bone loss (MBL) and with healthy peri-implant (HI) tissues. Twenty-one individuals who didn't have any dental implants were included the study as a healthy control group (HC). For oxidant concentration, total oxidant status (TOS), advanced oxidation protein products (AOPP), and for antioxidant concentration, total antioxidant status (TAS), were investigated.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
Countries--

Timeline

N/ACompletedFinished
2017201820192020202120222023202420252026
First PostedFeb 13, 2023
Enrollment StartSep 1, 2016
Primary CompletionJan 5, 2018
Study CompletionMar 13, 2018
TodayJul 2, 2026
Enrollment to primary: 1.3 yearsPosted 3.4 years ago